{"title":"抗菌药物管理团队专职药剂师实施的所有注射用例的干预评估","authors":"Sachiyo Obana, Akari Yoshida, Ayako Chimori, Takakazu Kuwana, K. Ueno, Hidekatsu Fukuda, Satoshi Takashima, Mitsunari Yamamoto","doi":"10.5649/jjphcs.47.192","DOIUrl":null,"url":null,"abstract":"The antimicrobial stewardship team (AST) plays an important role in assisting with the treatment of infectious diseases. In August 2018, we started a program to dedicate a pharmacist to the AST and performed consultations focusing on patients before receiving intravenous antibiotics and all patients receiving intravenous antibiotics. In this study, we inves-tigated the impact of full-time pharmacist interventions on antimicrobial stewardship pre- (August 2017 – July 2018) and post- (August 2018 – July 2019) intervention. The total number of consultations with the full-time pharmacist increased significantly at 71 and 252 consultations pre- and post-intervention, respectively. There was no significant difference in the intervention, and a total of 69 (pass rate 85.5 % ) and 230 (83.5 % ) prescription improvement proposals were made pre- and post-intervention, respectively ( P = 0.852). There was no difference in 30-day mortality pre- and post-intervention. Additionally, as compared to the period from August 2017 to July 2018, that is, before the intervention, Antimicrobial Use Density (AUD) / Days of Therapy (DOT) for carbapenem antibiotics decreased from 0.73 to 0.58 during the intervention period ( P = 0.004). Based on these results, we suggest that the implementation of aggressive consultations and interventions by the full-time pharmacist is useful for promoting the appropriate treatment.","PeriodicalId":14574,"journal":{"name":"Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)","volume":"42 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-04-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Intervention Evaluation for All Injectable Antimicrobial Use Cases Practiced by Full-time Pharmacist in the Antimicrobial Stewardship Team\",\"authors\":\"Sachiyo Obana, Akari Yoshida, Ayako Chimori, Takakazu Kuwana, K. Ueno, Hidekatsu Fukuda, Satoshi Takashima, Mitsunari Yamamoto\",\"doi\":\"10.5649/jjphcs.47.192\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The antimicrobial stewardship team (AST) plays an important role in assisting with the treatment of infectious diseases. In August 2018, we started a program to dedicate a pharmacist to the AST and performed consultations focusing on patients before receiving intravenous antibiotics and all patients receiving intravenous antibiotics. In this study, we inves-tigated the impact of full-time pharmacist interventions on antimicrobial stewardship pre- (August 2017 – July 2018) and post- (August 2018 – July 2019) intervention. The total number of consultations with the full-time pharmacist increased significantly at 71 and 252 consultations pre- and post-intervention, respectively. There was no significant difference in the intervention, and a total of 69 (pass rate 85.5 % ) and 230 (83.5 % ) prescription improvement proposals were made pre- and post-intervention, respectively ( P = 0.852). There was no difference in 30-day mortality pre- and post-intervention. Additionally, as compared to the period from August 2017 to July 2018, that is, before the intervention, Antimicrobial Use Density (AUD) / Days of Therapy (DOT) for carbapenem antibiotics decreased from 0.73 to 0.58 during the intervention period ( P = 0.004). Based on these results, we suggest that the implementation of aggressive consultations and interventions by the full-time pharmacist is useful for promoting the appropriate treatment.\",\"PeriodicalId\":14574,\"journal\":{\"name\":\"Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)\",\"volume\":\"42 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-04-10\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5649/jjphcs.47.192\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5649/jjphcs.47.192","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Intervention Evaluation for All Injectable Antimicrobial Use Cases Practiced by Full-time Pharmacist in the Antimicrobial Stewardship Team
The antimicrobial stewardship team (AST) plays an important role in assisting with the treatment of infectious diseases. In August 2018, we started a program to dedicate a pharmacist to the AST and performed consultations focusing on patients before receiving intravenous antibiotics and all patients receiving intravenous antibiotics. In this study, we inves-tigated the impact of full-time pharmacist interventions on antimicrobial stewardship pre- (August 2017 – July 2018) and post- (August 2018 – July 2019) intervention. The total number of consultations with the full-time pharmacist increased significantly at 71 and 252 consultations pre- and post-intervention, respectively. There was no significant difference in the intervention, and a total of 69 (pass rate 85.5 % ) and 230 (83.5 % ) prescription improvement proposals were made pre- and post-intervention, respectively ( P = 0.852). There was no difference in 30-day mortality pre- and post-intervention. Additionally, as compared to the period from August 2017 to July 2018, that is, before the intervention, Antimicrobial Use Density (AUD) / Days of Therapy (DOT) for carbapenem antibiotics decreased from 0.73 to 0.58 during the intervention period ( P = 0.004). Based on these results, we suggest that the implementation of aggressive consultations and interventions by the full-time pharmacist is useful for promoting the appropriate treatment.